Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Biomed Research International|October 23, 2015
T Lymphocyte Inhibition by Tumor-Infiltrating Dendritic Cells Involves Ectonucleotidase CD39 but Not Arginase-1Malika Trad, Alexandrine Gautheron, Jennifer Fraszczak, et al.JAMA Oncology|October 8, 2020
Systemic Anti-PD-1 Immunotherapy Results in PD-1 Blockade on T Cells in the Cerebrospinal FluidJana Portnow, Dongrui Wang, M Suzette Blanchard, et al.Cancer Research Communications|March 27, 2023
Inclusion of 4-1BB Costimulation Enhances Selectivity and Functionality of IL13Rα2-Targeted Chimeric Antigen Receptor T CellsRenate Starr, Brenda Aguilar, Diana Gumber, et al.Plos One|February 2, 2016
Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma ModelMao Ouyang, Ethan E White, Hui Ren, et al.Cancer Research|July 23, 2014
TLR9 is critical for glioma stem cell maintenance and targetingAndreas Herrmann, Gregory Cherryholmes, Anne Schroeder, et al.Science Translational Medicine|March 6, 2020
Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastomaDongrui Wang, Renate Starr, Wen-Chung Chang, et al.Cancer Discovery|April 10, 2021
IFNγ Is Critical for CAR T Cell-Mediated Myeloid Activation and Induction of Endogenous ImmunityDarya Alizadeh, Robyn A Wong, Sharareh Gholamin, et al.Biorxiv : the Preprint Server for Biology|April 17, 2026
Meditope-Enabled Chimeric Antigen Receptors Facilitate Plug-and-Play Control of T CellsCheng-Fu Kuo, Zhen Tong, Yi-Chiu Kuo, et al.Cancer Discovery|December 17, 2020
CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based TherapiesDongrui Wang, Briana C Prager, Ryan C Gimple, et al.Biorxiv : the Preprint Server for Biology|April 16, 2025
Overcoming myeloid-driven resistance to CAR T therapy by targeting SPP1Sharareh Gholamin, Heini M Natri, Yuqi Zhao, et al.Pageof 5